A detailed history of Dynamic Advisor Solutions LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Dynamic Advisor Solutions LLC holds 483 shares of REGN stock, worth $357,424. This represents 0.02% of its overall portfolio holdings.

Number of Shares
483
Previous 508 4.92%
Holding current value
$357,424
Previous $533,000 4.88%
% of portfolio
0.02%
Previous 0.02%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$1024.09 - $1201.76 $25,602 - $30,044
-25 Reduced 4.92%
483 $507,000
Q2 2024

Jul 15, 2024

SELL
$883.2 - $1071.19 $72,422 - $87,837
-82 Reduced 13.9%
508 $533,000
Q1 2024

Apr 12, 2024

SELL
$902.69 - $993.35 $259,072 - $285,091
-287 Reduced 32.73%
590 $567,000
Q4 2023

Jan 10, 2024

BUY
$775.18 - $881.7 $79,843 - $90,815
103 Added 13.31%
877 $770,000
Q3 2023

Oct 10, 2023

BUY
$692.45 - $844.37 $218,121 - $265,976
315 Added 68.63%
774 $636,000
Q2 2023

Aug 03, 2023

SELL
$700.03 - $830.35 $2,100 - $2,491
-3 Reduced 0.65%
459 $329,000
Q1 2023

Apr 10, 2023

BUY
$680.49 - $826.97 $23,817 - $28,943
35 Added 8.2%
462 $379,000
Q4 2022

Jan 12, 2023

SELL
$705.89 - $766.39 $4,941 - $5,364
-7 Reduced 1.61%
427 $0
Q3 2022

Oct 20, 2022

BUY
$573.97 - $724.32 $14,923 - $18,832
26 Added 6.37%
434 $299,000
Q2 2022

Jul 27, 2022

SELL
$548.35 - $738.84 $7,128 - $9,604
-13 Reduced 3.09%
408 $241,000
Q1 2022

Apr 11, 2022

SELL
$595.12 - $698.43 $16,663 - $19,556
-28 Reduced 6.24%
421 $294,000
Q4 2021

Jan 26, 2022

BUY
$543.48 - $670.97 $36,956 - $45,625
68 Added 17.85%
449 $283,000
Q3 2021

Oct 28, 2021

BUY
$574.03 - $680.96 $218,705 - $259,445
381 New
381 $231,000
Q3 2020

Oct 27, 2020

SELL
$544.75 - $658.21 $207,005 - $250,119
-380 Closed
0 $0
Q2 2020

Aug 05, 2020

BUY
$493.32 - $643.92 $187,461 - $244,689
380 New
380 $237,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $79.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Dynamic Advisor Solutions LLC Portfolio

Follow Dynamic Advisor Solutions LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Advisor Solutions LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Advisor Solutions LLC with notifications on news.